Morning Research: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc.

Fri Oct 4, 2013 9:05am EDT

* Reuters is not responsible for the content in this press release.

Morning Research: Johnson & Johnson, Mylan Inc., Brookdale Senior Living Inc., and Array BioPharma Inc.

Editor Note: For more information about this release, please scroll to bottom.

PR Newswire

LONDON, October 4, 2013 /PRNewswire/ --

The U.S. equity market posted losses on Thursday, October 03, 2013. The S&P 500 ended the day at 1,678.66, down 0.90%; the Dow Jones Industrial Average closed at 14,996.48, down 0.90%; and the NASDAQ Composite finished at 3,774.34, down 1.07%. Shares in the healthcare sector mostly edged lower, tracking losses in the broader market. The major movers in the sector included Johnson & Johnson (NYSE: JNJ), Mylan Inc. (NASDAQ: MYL), Brookdale Senior Living Inc. (NYSE: BKD), and Array Biopharma Inc. (NASDAQ: ARRY). AAAResearchReports.com has released full comprehensive research on JNJ, MYL, BKD, and ARRY. These free technical analyses can be downloaded by signing up at:

http://www.aaaresearchreports.com/register/  

Shares in Johnson & Johnson edged lower on Thursday, extending losses from the previous trading session. The company's shares oscillated between $86.28 and $87.40 before finishing the day 0.81% lower at $86.58. A total of 7.72 million shares were traded, which is below the daily average volume of 8.71 million. Despite Thursday's losses, Johnson & Johnson's stock has advanced 0.19% in the last one month, compared to a gain of 2.37% in the S&P 500 during the same period. Additionally, the company's shares are trading below its 50-day and 200-day moving averages of $88.31 and $86.81, respectively. Download free report on JNJ upon registration at:

http://www.AAAResearchReports.com/JNJ100413.pdf  

On Thursday, Mylan Inc.'s stock rose sharply, hitting a new 52-week high of $40.22. The company's shares closed the day at $39.99, up 1.27% from the previous day's price of $39.49. A total of 6.33 million shares were traded, which is above the daily average volume of 4.11 million. Mylan Inc.'s shares have rallied 11.99% in the last one month and 31.24% in the previous three months, outperforming the S&P 500 which has gained 2.37% and 3.92% during the respective periods. Furthermore, the company's stock is currently trading above its 50-day and 200-day moving averages of $37.09 and $32.46, respectively. MYL technical report can be accessed for free by signing up at:

http://www.AAAResearchReports.com/MYL100413.pdf  

Brookdale Senior Living Inc.'s shares fell sharply on Thursday, extending their losses from the previous trading session. The company's shares vacillated between $26.00 and $26.85 before finishing the day 2.02% lower at $26.18. A total of 1.81 million shares were traded, which is above the daily average volume of 1.24 million. Despite Thursday's sharp decline, the company's shares have gained 4.76% in the last one month, outperforming the S&P 500 which has advanced 2.37% during the same period. Additionally, Brookdale Senior Living Inc.'s stock is trading below its 50-day and 200-day moving averages of $26.25 and $27.46, respectively. The free report on BKD can be downloaded by signing up now at:

http://www.AAAResearchReports.com/BKD100413.pdf  

Shares in Array Biopharma Inc. fell by 0.15% on Thursday, reversing some of the gains from the previous trading session. The company's shares closed the day at $6.58, after fluctuating between $6.44 and $6.66. A total of 2.74 million shares were traded, which is above the daily average volume of 1.90 million. Despite Thursday's losses, the company's shares have surged 13.25% in the last one month and 34.01% in the previous three months, outperforming the S&P 500 which has gained 2.37% and 3.92% during the respective periods. Furthermore, Array Biopharma Inc.'s stock is trading above its 50-day and 200-day moving averages of $6.05 and $5.59, respectively. A free report on ARRY can be accessed by registering at:

http://www.AAAResearchReports.com/ARRY100413.pdf  

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AAAresearchreports.com


SOURCE AAA Research Reports

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.